In this chaotic news cycle it may be tempting to tune out, but we hope you won’t—only an informed and engaged public can defend democracy. In these times of deep political polarization we need news that goes beyond play-by-play headlines, news that goes to the heart of each story by asking people to tell their own stories of abuses of power and injustice in their own words. If our journalism is important to you, please donate today. Every dollar makes a difference. Thank you so much.
Democracy Now!
Amy Goodman
In this chaotic news cycle it may be tempting to tune out, but we hope you won’t—only an informed and engaged public can defend democracy. In these times of deep political polarization we need news that goes beyond play-by-play headlines, news that goes to the heart of each story by asking people to tell their own stories of abuses of power and injustice in their own words. If our journalism is important to you, please donate today. Every dollar makes a difference. Thank you so much.
Democracy Now!
Amy Goodman
We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.
Please do your part today.
StoryMay 20, 2025
StoryMay 20, 2025
StoryMay 20, 2025
StoryMay 19, 2025
Web ExclusiveMay 13, 2025
Web ExclusiveMay 09, 2025
Web ExclusiveApr 21, 2025
Web ExclusiveApr 17, 2025
In medical news, a draft manuscript of a report from a long-awaited clinical trial in China finds the antiviral drug remdesivir failed to lower the death rates or recovery times of COVID-19 patients. The findings have not yet passed peer review.
Preliminary results of a study by the New York state Department of Health showed the drug touted by President Trump as a curative for COVID-19 — hydroxychloroquine — had no effect on patients’ recoveries.
We're hiring a Director of Audience and a Director of Technology!
Top